November 22nd (Eastern Time) - $Citius Pharmaceuticals (CTXR.US)$ is about to implement a 1-for-25 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from November 26th, 2024.
$Citius Pharmaceuticals (CTXR.US)$ slipped 2.83% and closed at $0.1651 on November 21st with a turnover of $777.99K. $Citius Pharmaceuticals (CTXR.US)$ now has a total market capitalization of $31.89 million.
What Is a Reverse Stock Split?
A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.
Note:
The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.